By Richard A. Lewis, MD - Chief Medical Editor
Intracranial pressure may hold the key to understanding why IOP plays a major role in the development of glaucoma.
By John Berdahl, MD
An overview of the requirements for success.
By Craig Marcus, MD
How I achieve a watertight seal.
By Garry P. Condon, MD
A new algorithm may help clinicians to determine the cause of visual field loss in patients with coexisting drusen and glaucoma.
By Huijuan Wu, MD, PhD; Johannes F. de Boer, PhD; and Teresa C. Chen, MD
Experience-based advice on management.
By Donald L. Budenz, MD, MPH
How to proceed when filtering surgery is too effective.
By Amy Badger, MD; Todd Perkins, MD; Geoffrey T. Emerick, MD; and Michael C. Stiles, MD
An understanding of wound healing and predisposing risk factors will help surgeons in their rescue efforts.
By Nils A. Loewen, MD, PhD, and James C. Tsai, MD
Diagnosis, risk factors, and the treatment of blebitis and bleb-related endophthalmitis.
By JoAnn A. Giaconi, MD
By Scott J. Fudemberg, MD; Parul Ichhpujani, MD; and Marlene R. Moster, MD
Guidelines for incorporating new diagnostic and surgical techniques into an established glaucoma practice.
By Steven D. Vold, MD
By Nathan M. Radcliffe, MD
Dr. Smit reveals why she switched professions and describes how she uses laser trabeculoplasty.
By Barbara A. Smit, MD, PhD
Investigators from South Africa evaluated six glaucoma tests to determine which were suitable for use in the United Nations' Vision 2020 screening programs.1 The participants in the study included normal controls (32 individuals r... more >
Endo Optiks, Inc. (Little Silver, NJ), launched a series of high-resolution microendoscopes during the 2009 ESCRS meeting in Barcelona, Spain. These instruments are approved in the United States for use during endoscopic cyclophot... more >
Abbott (Abbott Park, IL) has announced a definitive agreement to acquire Visiogen, Inc. (Irvine, CA), for $400 million in cash. The acquisition will provide Abbott with Visiogen's Synchrony accommodating IOL, which is currently un... more >
Aton Pharma, Inc. (Lawrenceville, NJ), has launched a new educational, distribution, sampling, and reimbursement program for preservative-free Timoptic Ocudose (timolol maleate). Earlier this year, the company acquired the exclusi... more >
advertisement
Intracranial pressure may hold the key to understanding why IOP plays a major role in the development of glaucoma.
by John Berdahl, MD
A new algorithm may help clinicians to determine the cause of visual field loss in patients with coexisting drusen and glaucoma.
by Huijuan Wu, MD, PhD; Johannes F. de Boer, PhD; and Teresa C. Chen, MD
by Richard A. Lewis, MD - Chief Medical Editor
How to proceed when filtering surgery is too effective.
by Amy Badger, MD; Todd Perkins, MD; Geoffrey T. Emerick, MD; and Michael C. Stiles, MD
An understanding of wound healing and predisposing risk factors will help surgeons in their rescue efforts.
by Nils A. Loewen, MD, PhD, and James C. Tsai, MD